Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10017598HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017499HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017500HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017750HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017706HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017631HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017943HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10018561HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10012324HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10013109HBVENSG00000163631.19protein_codingALBNoNo213P02768
TCGA Plot Options
Drug Information
GeneALB
DrugBank IDDB00276
Drug NameAmsacrine
Target IDBE0000530
UniProt IDP02768
Regulation Type
PubMed IDs10803926
CitationsFinlay GJ, Baguley BC: Effects of protein binding on the in vitro activity of antitumour acridine derivatives and related anticancer drugs. Cancer Chemother Pharmacol. 2000;45(5):417-22.
GroupsApproved; Investigational
Direct ClassificationAcridines
SMILESCOC1=C(NC2=C3C=CC=CC3=NC3=CC=CC=C23)C=CC(NS(C)(=O)=O)=C1
Pathways
PharmGKBPA10309
ChEMBLCHEMBL43